Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Arrow Global Prices IPO - Quick Facts

Arrow Global Group plc, a consumer debt purchaser and provider of receivables management solutions, announced it has priced initial public offering at 205 pence per ordinary share. The offer is expected to raise gross proceeds of approximately 50.0 million pounds for the company. The offer comprises 92,139,603 ordinary shares, representing 52.8 percent, of the company's ordinary shares.

Arrow Global said conditional dealings will commence on the London Stock Exchange at 8.00 a.m., October 8, under the ticker ARW. The Group expects admission to the premium listing segment of the official list, admission of the shares to trading on the main market for listed securities of the London Stock Exchange and the commencement of unconditional dealings in the ordinary shares to take place at 8.00 a.m. on 11 October 2013.

Immediately following Admission, RBS SOF will continue to hold 29.2 percent of the company's ordinary shares, which are subject to a 180 day lock-up.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Stocks came under pressure in early trading on Friday and remained firmly in the red throughout the remainder of the trading session. With the losses on the day, the S&P 500 pulled back well off yesterday's record closing high. President Barack Obama is meeting with presidents from Central American nations on Friday as the U.S. struggles to deal with a surge of unaccompanied children across the southern border. Despite calls from some leading conservatives, the results of a new CNN/ORC International poll released Friday showed that a vast majority of Americans do not believe that President Barack Obama should be impeached and removed from office.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.